Prostatic Tumour Tissue Microarray

Prostate tumour tissue microarray (TMA) is a powerful tool that streamlines high-throughput analysis of prostate cancer by enabling the simultaneous evaluation of multiple tissue samples on a single slide. This technique involves extracting small core biopsies from different prostate tumour specimens and embedding them into a single paraffin block. The resulting array allows researchers to study biomarker expression, tumour heterogeneity, disease progression, and therapeutic targets across a large number of cases in a consistent and standardized format. 

Our Prostatic Tumour Tissue Microarrays

Our Prostatic Tumour TMAs contain well-characterized tissue samples derived from Southeast Asian populations, providing a unique and valuable resource for biomarker discovery, novel drug validation, and translational research. At MYmAb Biologics, we use only IRB-approved specimens to ensure our products meet ethical standards and deliver reliable results for scientific studies. Visit our product page or contact us to learn more about our prostatic tumour TMA today.

  • Prostatic Tumour Tissue Microarray

    Prostatic Tumour Tissue Microarray (50 cases) – TP002

    Read more

Benefits of Prostatic Tumour Tissue Microarrays

Prostatic tumour tissue microarrays offer numerous advantages for researchers seeking efficient, large-scale tissue analysis:

  • High Efficiency: Analyze multiple samples simultaneously, saving time and laboratory resources.
  • Cost-Effective: Reduce reagent and consumable usage compared to traditional slide-based studies.
  • Standardized Data: Maintain consistency across experiments with uniform sample processing.
  • Broad Sample Representation: Study diverse tissue types, cancer subtypes, and patient demographics in one microarray.
  • Custom Solutions: Tailor TMAs to specific research needs, ensuring relevant and focused analysis.

Applications of Prostatic Tumour TMAs in Cancer Research

  • Novel Biomarker: Identification of new protein markers for diagnostic and prognostic of prostate cancer.
  • Treatment Validation: Evaluation of novel drugs and therapies using human samples during the pre-clinical stage.
  • Personalized Medicine: Incorporation of regional genetic trends and molecular profiles to develop precise and targeted therapeutic solutions.

Why Choose Our Prostate Tumour Tissue Microarray

MYmAb Biologics ethically produces human tissue microarrays (TMAs) through our ArrayZeal platform, guided by strict ethical standards and built on a foundation of precision and reliability. Each TMA is carefully constructed using clinically validated human tissue samples sourced from diverse Southeast Asian populations. This ensure better representation of ethic genetic variability, which is an important factor that influences disease progression and treatment responses. Committed to delivering reliable and reproducible results, ArrayZeal support robust scientific discoveries and accelerate translational research. By offering Southeast Asian-derived TMAs, we empower researchers to explore novel therapies within a broader genetic context, paving the way for groundbreaking discoveries and personalized medicine.

Frequently Asked Questions

Conventionally, immunohistochemical staining has been performed on whole tissue sections. However, this traditional method, which requires the processing and staining of hundreds or even thousands of slides, is time-consuming and expensive. In contrast, a TMA allows simultaneous analysis of hundreds of tissues in one go using identical conditions. Thus, TMA technology markedly conserves reagents, saves time and greatly decreases the amount of archival tissue required for a particular study, thus preserving the tissues for other diagnostic and/or research needs.

A core size of 0.6 to 2.0 mm is adequate to represent the whole tissue section.

Sometimes, a small core of sample may not be representative of the whole tumour, especially in heterogenous tumour types. To overcome this, we offer TMAs that include two to three cores of samples from different locations of a single tumour block.

Negative and positive control TMA slides should be included as they are important in ensuring the validity of the experiment.

A minimum of 3 slides per TMA type to include positive and negative controls.

Yes. You may contact us for further details and discuss on your needs.

The TMAs are sent in ambient temperature.

We recommend you to store your TMA slides at 4°C for not more than a year.

Request for Quote

Location:
Block D-G-8, UPM-MTDC Technology Centre III, Universiti Putra Malaysia, 43400 Serdang, Selangor Darul Ehsan, Malaysia.

Phone:
03-8938 9819

Email:
info.mymab@gmail.com

Contact us form